Breaking Gene Therapy News
-
Astellas hits another gene therapy clinical hold—Fierce Pharm Asia - FiercePharma
Jul 1, 2022 | 15:40 pmAstellas hits another gene therapy clinical hold—Fierce Pharm Asia FiercePharma
Read more... -
As gene therapies proliferate, a risk of 'cost shock' looms - FiercePharma
Jun 30, 2022 | 17:40 pmAs gene therapies proliferate, a risk of 'cost shock' looms FiercePharma
Read more... -
Scoop: A small gene therapy biotech, flush with ex-Sarepta and bluebird leaders, guts CMC - Endpoints News
Jun 30, 2022 | 16:27 pmScoop: A small gene therapy biotech, flush with ex-Sarepta and bluebird leaders, guts CMC Endpoints News
Read more... -
HKUMed researchers discover more efficient CRISPR-Cas9 variants for gene therapy applications - News-Medical.Net
Jun 30, 2022 | 07:17 amHKUMed researchers discover more efficient CRISPR-Cas9 variants for gene therapy applications News-Medical.Net
Read more... -
Philadelphia region's cell and gene therapy jobs increased 127% since 2019 - Philadelphia Business Journal - The Business Journals
Jun 29, 2022 | 20:37 pmPhiladelphia region's cell and gene therapy jobs increased 127% since 2019 - Philadelphia Business Journal The Business Journals
Read more... -
Gene therapy for macular degeneration: Uses and more - Medical News Today
Jun 29, 2022 | 09:00 amGene therapy for macular degeneration: Uses and more Medical News Today
Read more... -
Precision, Novartis Partner to Develop Custom Sickle Cell Gene Therapy - Sickle Cell Anemia News
Jun 28, 2022 | 15:55 pmPrecision, Novartis Partner to Develop Custom Sickle Cell Gene Therapy Sickle Cell Anemia News
Read more... -
Astellas' gene therapy strategy faces fresh setback as FDA puts Pompe disease med on hold - FierceBiotech
Jun 27, 2022 | 15:03 pmAstellas' gene therapy strategy faces fresh setback as FDA puts Pompe disease med on hold FierceBiotech
Read more... -
BioMarin's hemophilia gene therapy wins conditional EU backing - FiercePharma
Jun 24, 2022 | 09:00 amBioMarin's hemophilia gene therapy wins conditional EU backing FiercePharma
Read more... -
Uniqure's Huntington's gene therapy lowers key protein in small trial - STAT
Jun 23, 2022 | 09:00 amUniqure's Huntington's gene therapy lowers key protein in small trial STAT
Read more... -
Gene therapy: The Potential for Treating Type 1 Diabetes - Healthline
Jun 22, 2022 | 09:00 amGene therapy: The Potential for Treating Type 1 Diabetes Healthline
Read more... -
Startup will target cystic fibrosis with a new twist on gene therapy - STAT
Jun 21, 2022 | 09:00 amStartup will target cystic fibrosis with a new twist on gene therapy STAT
Read more... -
New gene therapy improvement has massive potential - Drug Target Review
Jun 20, 2022 | 09:00 amNew gene therapy improvement has massive potential Drug Target Review
Read more... -
New way forward for gene therapy - Medical Xpress
Jun 15, 2022 | 09:00 amNew way forward for gene therapy Medical Xpress
Read more... -
Drug Target Review Cell & Gene Therapy ebook - Drug Target Review
Jun 15, 2022 | 09:00 amDrug Target Review Cell & Gene Therapy ebook Drug Target Review
Read more... -
New gene therapy treatment promises to transform rare blood disorder - USA TODAY
Jun 14, 2022 | 09:00 amNew gene therapy treatment promises to transform rare blood disorder USA TODAY
Read more... -
Bluebird backing boosts beleaguered gene therapy space - Vantage
Jun 13, 2022 | 09:00 amBluebird backing boosts beleaguered gene therapy space Vantage
Read more... -
Charles River and ASC Therapeutics expand gene therapy manufacturing agreement - BioPharma-Reporter.com
Jun 13, 2022 | 09:00 amCharles River and ASC Therapeutics expand gene therapy manufacturing agreement BioPharma-Reporter.com
Read more... -
Astellas, despite recent setbacks, opens $100M gene therapy plant - BioPharma Dive
Jun 8, 2022 | 09:00 amAstellas, despite recent setbacks, opens $100M gene therapy plant BioPharma Dive
Read more... -
Mouse study shows gene therapy could fight against rare disease - Drug Target Review
Jun 7, 2022 | 09:00 amMouse study shows gene therapy could fight against rare disease Drug Target Review
Read more...